title: Ictal motor signs and interictal regional cerebral hypometabolism.
abstract: Early motor manifestations are the main components of focal seizures involving the frontal lobe. We examined the relationship between the initial ictal motor manifestations and interictal abnormalities of cerebral glucose consumption (rCMRGlc) as assessed by PET in 48 consecutive patients with focal seizures of neocortical origin. Group data analysis revealed that patients with predominantly unilateral clonic seizures had a significant contralateral perirolandic hypometabolism and to a lesser degree a contralateral frontomesial hypometabolism. Patients with predominantly focal tonic manifestations showed a hypometabolism within the frontomesial and perirolandic regions that was unilateral in all patients with lateralized tonic seizures. Patients with versive seizures had mainly contralateral metabolic depressions without a consistent regional pattern. Patients with hypermotor seizures had metabolic depressions involving frontomesial, anterior cingulate, perirolandic, and anterior insular/frontal operculum areas. In all patient groups, bilateral and symmetric hypometabolism of the thalamus and cerebellum was observed. We propose that this pattern of distinctly abnormal metabolic brain regions demonstrates not only possible epileptogenic zones but also symptomatogenic brain regions as shown by the associations between clinical manifestations and sets of abnormal brain regions, particularly if epileptogenic zones are in a clinically silent neocortical brain region. The detection and possible differentiation of symptomatogenic and epileptogenic zones might improve the effectiveness of presurgical noninvasive studies.
authors.affiliation: Department of Neurology, Heinrich-Heine-University Düsseldorf, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Schlaug
authors.forename: C
authors.initials: C
authors.lastname: Antke
authors.forename: H
authors.initials: H
authors.lastname: Holthausen
authors.forename: S
authors.initials: S
authors.lastname: Arnold
authors.forename: A
authors.initials: A
authors.lastname: Ebner
authors.forename: I
authors.initials: I
authors.lastname: Tuxhorn
authors.forename: L
authors.initials: L
authors.lastname: Jäncke
authors.forename: H
authors.initials: H
authors.lastname: Lüders
authors.forename: O W
authors.initials: OW
authors.lastname: Witte
authors.forename: R J
authors.initials: RJ
authors.lastname: Seitz
mesh_terms: D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000473:pathology; D003847:Deoxyglucose / Q000031:analogs & derivatives; D004569:Electroencephalography; D004827:Epilepsy / Q000175:diagnosis / Q000378:metabolism* / Q000503:physiopathology*; D005260:Female; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D009068:Movement; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose